IRCT201308181159N9CompletedPhase 3
Comparison of the efficacy and safety of Q-Switch 1,064 nm Nd:YAG Laser with and without carbon photo enhancer lotion on reducing skin pigmentation in patients with Melasma referred to Skin and Stem cell research center of Tehran University of Medical Sciences
Vice Chancellor for Research, Tehran University of Medical Sciences0 sites43 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 43
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 85 years (—)
- Sex
- All
Inclusion Criteria
- •Age between 18 and 85 years old; Fitzpatrick skin type I-V; symmetric distribution of melasma the in both sides of patient's face;
- •Exclusion criteria: -usage of pigment reducing topical treatments 2 weeks prior to the study -usage of peeling agents 2 weeks prior to the study -laser therapy for melasma 1 month prior to the study, and solarium usage one month prior to the treatment.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Not yet recruiting
Phase 2
Evaluation Efficacy and side effects of Q switched Nd:YAG versus fractional Er:YAG in lip rejuvenatioRejuvenation.IRCT20240801062612N1Shahid Beheshti University of Medical Sciences86
Not yet recruiting
Not Applicable
aser treatment of lichen planus pigmentosus and pigmented contact dermatitis.CTRI/2019/09/021361All India Institute of Medical Sceinces
Completed
Not Applicable
Prospective study of effecacy and safety of switch from oral medicine of tramadolto fentanyl sticking medicine (dyuroteppu MT patch on the 3rd) in lung cancer and malignant pleura mesothelioma with the pailung cancer, malignant mesotheliomaJPRN-UMIN000005620Osaka Prefectural Medical Center for Respiratory and Allergic Diseases15
Completed
Not Applicable
Evaluation of the efficacy and safety for switching from premixed insulin to ultra-long acting insulin plus ultra-rapid insulitype 2 diabetesJPRN-UMIN000009562Department of Endocrinology and Metabolism, Nagoya City West Medical Center40
Completed
Not Applicable
Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetestype 2 diabetesJPRN-UMIN000013222Juntendo University Graduate School of Medicine30